APPLICATION
ANDA090260
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-15
LATEST ACTION
2010-11-23
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Prescription
Products
LORAZEPAMPrescription
LORAZEPAM 2MG/ML · CONCENTRATE · ORAL
Approval history
2010-11-23Labeling · Supplement 1AP
2010-06-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.